Amphastar Pharmaceuticals, Inc.AMPHNASDAQ
Loading
Earnings before interest, taxes, depreciation, and amortization
3Y CAGR
+0.7%/yr
vs +115.1%/yr prior
5Y CAGR
+37.6%/yr
Recent deceleration
Acceleration
-114.4pp
Decelerating
Percentile
P86
Within normal range
vs 5Y Ago
4.9x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $149.10M | -46.2% |
| 2024 | $277.31M | +15.4% |
| 2023 | $240.29M | +64.4% |
| 2022 | $146.16M | +31.0% |
| 2021 | $111.56M | +269.5% |
| 2020 | $30.19M | -62.9% |
| 2019 | $81.47M | +1092.3% |
| 2018 | $6.83M | -42.6% |
| 2017 | $11.90M | -61.0% |
| 2016 | $30.53M | - |